Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter

Details for Australian Patent Application No. 2003267967 (hide)

International Classifications

Event Publications

8 January 2004 Complete Application Filed

Priority application(s): 60/389,612 18.06.02 US

26 February 2004 Application Open to Public Inspection

Published as AU-B-2003267967

27 January 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 21 Dec 2004

10 March 2005 Section 223 Application Received

ZymoGenetics, Inc. An application to extend the time from 31 Dec 2003 to 31 Jan 2005 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

5 May 2005 Section 223 Application Allowed

ZymoGenetics, Inc. The time in which to comply with Section 6(c) has been extended to 31 Jan 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 November 2008 Application Accepted

Published as AU-B-2003267967

19 March 2009 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.